Welcome to our dedicated page for Eastman Chem Co SEC filings (Ticker: EMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking volatile raw-material costs, environmental liabilities, and margin swings across Eastman Chemical’s four operating segments can feel like piecing together a complex polymer chain. Questions such as “where can I find Eastman Chemical’s quarterly earnings report 10-Q filing?� or “how do I read an Eastman Chemical proxy statement executive compensation?� surface daily. Each disclosure is packed with sustainability metrics, molecular recycling updates, and global demand commentary that most investors struggle to extract.
Stock Titan solves that problem with AI-powered summaries and real-time EDGAR alerts. Whether you need an Eastman Chemical insider trading Form 4 transactions feed or want Eastman Chemical SEC filings explained simply, our platform delivers. All filing types arrive seconds after the SEC posts them, and our machine learning highlights the passages that move markets:
- 10-K annual report insights, including chemical feedstock sensitivity, now Eastman Chemical annual report 10-K simplified
- 10-Q trend dashboards that turn raw data into Eastman Chemical earnings report filing analysis
- 8-K event monitors with Eastman Chemical 8-K material events explained in plain English
- Form 4 alerts for Eastman Chemical executive stock transactions Form 4 in real time
Use these tools to compare segment performance, flag environmental remediation commitments, or watch management’s share purchases before capital-intensive projects. Analysts rely on our platform for “understanding Eastman Chemical SEC documents with AI,� while portfolio managers track “Eastman Chemical Form 4 insider transactions real-time� to gauge insider sentiment. With comprehensive coverage, expert commentary, and AI that speaks your language, you’ll move beyond document hunting to informed decision-making.
Adrian James Holt, Senior Vice President and Chief Human Resources Officer of Eastman Chemical Company (EMN), reported an acquisition on 08/28/2025 of 2,200 Phantom Stock Units under the company Executive Deferred Compensation Plan. Each phantom unit has a value equal to one share of common stock and is payable only in cash, subject to certain acceleration and early withdrawal provisions. The report shows a deemed price of $68.18 per share and lists 2,200 units beneficially owned following the transaction, held directly. The Form 4 was signed by Mark D. Austin by power of attorney on 08/29/2025.
Insider purchases and deferred-compensation award reported for Eastman Chemical (EMN)
Brian Travis Smith, an executive (EVP, AFP, Mfg., WWEC & HSE) reported acquiring 1,750 shares of Eastman common stock at a price of $68.34 per share, bringing his direct beneficial ownership to 16,732 shares. Separately, he was credited with 2,200 phantom stock units under the company Executive Deferred Compensation Plan; those units have a value tied to the company common stock at $68.18 per share and are payable in cash, with the report showing 2,208 underlying shares equivalent following the award. The phantom units are subject to plan terms including limited acceleration and withdrawal provisions and are payable after termination of employment. The filing reflects routine insider equity purchases and a deferred-compensation award that links pay to the issuer stock value.
James J. O'Brien, a director of Eastman Chemical Company (EMN), reported a purchase of company shares. On 08/27/2025 he acquired 1,450 shares of Common Stock at a price of $68.811 per share. After the transaction he beneficially owned 6,828 shares directly and had an indirect interest in 1,022 shares held in a revocable trust. The Form 4 was signed by Mark D. Austin by power of attorney on 08/28/2025.
Insider purchase reported: Eastman Chemical Company director Kim Ann Mink purchased 1,450 shares of EMN common stock on 08/27/2025 at a price of $69.3799 per share. After the transaction she beneficially owned 2,840 shares. The Form 4 was signed by Mark D. Austin by power of attorney on 08/28/2025. No derivative transactions or other comments are reported in the filing.
Julie Fasone, a director of Eastman Chemical Company (EMN), purchased 1,453 shares of the company's common stock on 08/27/2025 at a reported price of $68.8 per share. After this purchase she beneficially owned 17,546 shares in a direct ownership capacity. The Form 4 was filed as a single reporting person filing and the form was signed on behalf of Ms. Fasone by Mark D. Austin by power of attorney on 08/28/2025. The report discloses no derivative transactions and provides no additional remarks.
Eric L. Butler, identified as a director of Eastman Chemical Co. (EMN), reported a purchase of 3,000 shares of Common Stock on 08/27/2025 at a price of $68.6525 per share. Following the transaction, the filing reports 9,330 shares beneficially owned, held directly. The Form 4 was signed by Power of Attorney Mark D. Austin on 08/28/2025.
Brett D. Begemann, a director of Eastman Chemical Company (EMN), reported a purchase of 1,500 shares of the issuer's common stock on 08/27/2025 at a reported price of $68.285 per share. After the transaction, Mr. Begemann beneficially owned 9,520 shares. The Form 4 was signed on behalf of Mr. Begemann by Mark D. Austin under power of attorney on 08/28/2025.
Damon J. Audia, a director of Eastman Chemical Company (EMN), purchased 1,465 shares of common stock on 08/27/2025 at a price of $68.585 per share. After the transaction he beneficially owned 1,597 shares. The Form 4 was signed under power of attorney by Mark D. Austin on 08/28/2025. The filing reports a direct acquisition by a director and does not disclose derivative transactions.
Julie A. McAlindon, SVP, Regions & Chief Supply Chain Officer and director of Eastman Chemical Co. (EMN), purchased 2,000 shares of the issuer's common stock on 08/27/2025 at a reported price of $68.4294 per share. After the transaction she beneficially owned 12,731 shares directly and had indirect ownership of 867 shares through an ESOP. The Form 4 was signed by Mark D. Austin by power of attorney on 08/28/2025.
Insider purchase reported: Eastman Chemical Co. (EMN) executive Brad A. Lich purchased 3,280 shares of Common Stock on 08/27/2025 at a reported price of $68.49 per share. After the transaction, Mr. Lich beneficially owned 83,487 shares directly, plus 2,540 shares held through a 401(k) plan and 1,223 shares held through an ESOP.
FAQ
What is the current stock price of Eastman Chem Co (EMN)?
What is the market cap of Eastman Chem Co (EMN)?
